Conversation with The Cancer Letter

Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships

City of Hope has received a $50 million gift for a 190,000-square-foot outpatient center in Irvine, Calif.As a result of the gift, from Lennar Foundation, an offshoot of a building company, the facility, which is slated to be opened in 2022, will be named Lennar Foundation Cancer Center at City of Hope Orange County.

April 02, 2021

Vol.47 No.13

By Paul Goldberg

Conversation with The Cancer Letter

Targeted therapies and better outcomes for small cell lung cancer? NCI study on actionable germline mutations finds a link

A retrospective study conducted by a team of NCI researchers is dispelling the widely held notion that small cell lung cancer is almost exclusively tied to a history of smoking.

March 26, 2021

Vol.47 No.12

By Matthew Bin Han Ong

Cancer History Project Conversation with The Cancer Letter Free

NCCN’s Bob Carlson talks about the day he stormed out of a meeting with transplanters

In 1995, a group of doctors who advocated treating breast cancer with high dose chemotherapy with bone marrow transplantation made an attempt to include that highly toxic procedure in the guidelines of the nascent National Comprehensive Cancer Network.

March 26, 2021

Vol.47 No.12

By Paul Goldberg

Cancer History Project Conversation with The Cancer Letter Free

Bill McGivney: How NCCN guidelines came to play a role in payment for cancer therapy

Late in 1997, when Bruce Ross told me that Bill McGivney would replace him as CEO of the National Comprehensive Cancer Network, I thought the recruitment made sense.

March 19, 2021

Vol.47 No.11

By Paul Goldberg

Conversation with The Cancer Letter

Working in concert with NCI’s $500M data federation in childhood cancer, St. Jude demonstrates utility of its genomic database

NCI recently announced a master plan for its $500 million Childhood Cancer Data Initiative, a pilot project designed to set the stage for building a publicly accessible, comprehensive data federation for all cancers (The Cancer Letter, Dec. 4, 2020).

March 12, 2021

Vol.47 No.10

By Matthew Bin Han Ong

Cancer History Project Conversation with The Cancer Letter Free

Bob Young: NCCN is a case study in keeping what works and discarding what doesn’t

The National Comprehensive Cancer Network, an organization that promulgates guidelines based on standards of care provided at academic institutions in the U.S., is indisputably one of the pillars of oncology today.

March 12, 2021

Vol.47 No.10

By Paul Goldberg

Conversation with The Cancer Letter

Not for sale: Fox Chase Cancer Center

Last year, Fox Chase Cancer Center stood poised to make history by becoming the first NCI-designated cancer center to be sold on open market.

March 05, 2021

Vol.47 No.09

By Paul Goldberg

Conversation with The Cancer Letter

Kunle Odunsi: 50 years from now disparities—and metastatic disease—will be gone

On Monday, March 1, Adekunle “Kunle” Odunsi will become the director of the University of Chicago Comprehensive Cancer Center—and the second Black director of an NCI-designated cancer center.

February 26, 2021

Vol.47 No.08

By Robert A. Winn

Conversation with The Cancer Letter Free

A $250M gift creates Break Through Cancer foundation to focus five cancer centers on hard-to-treat diseases

Five academic cancer centers have formed a unique research alliance, Break Through Cancer, to focus on four cancer types—pancreatic cancer, ovarian cancer, glioblastoma, and acute myelogenous leukemia.

February 25, 2021

Vol.47 No.08

By Matthew Bin Han Ong and Paul Goldberg

Conversation with The Cancer Letter

Lori Pierce: Therapies are of no use when patients can’t get off work to be treated

As she became president of the American Society of Clinical Oncology, Lori J. Pierce decided to focus on equity in cancer care as her year-long presidential theme.

February 19, 2021

Vol.47 No.07

By Robert A. Winn

Conversation with The Cancer Letter

Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships

Targeted therapies and better outcomes for small cell lung cancer? NCI study on actionable germline mutations finds a link

NCCN’s Bob Carlson talks about the day he stormed out of a meeting with transplanters

Bill McGivney: How NCCN guidelines came to play a role in payment for cancer therapy

Working in concert with NCI’s $500M data federation in childhood cancer, St. Jude demonstrates utility of its genomic database

Bob Young: NCCN is a case study in keeping what works and discarding what doesn’t

Not for sale: Fox Chase Cancer Center

Kunle Odunsi: 50 years from now disparities—and metastatic disease—will be gone

A $250M gift creates Break Through Cancer foundation to focus five cancer centers on hard-to-treat diseases

Lori Pierce: Therapies are of no use when patients can’t get off work to be treated

Renew today!

Subscriber content

Login